J.P. Morgan Pulls Back on Hensoldt Amid Slower Growth and Rising Costs

J.P. Morgan has shifted its stance on Hensoldt AG (ETR:HAG.DE), cutting the rating from overweight to neutral. The German defense electronics firm, touted as a strategic player in its sector, now faces a slower ramp-up in sales and earnings than originally anticipated.

The downgrade follows Hensoldt's recent Capital Markets Day update, which revealed that revenue and EBITDA margin gains will materialize more slowly, pushing improvements further down the line. This forced the broker to trim its earnings forecast for 2025 through 2029 by up to 10%, reflecting a noticeably more cautious view on near-term profitability.

Investment expenditure remains substantial, as Hensoldt plows resources into expanding facility capacity and completing an extensive SAP system overhaul. These high costs, alongside growing capitalized research and development expenses, have squeezed free cash flow projections and extended exceptional operational costs through 2029-three years longer than J.P. Morgan initially expected.

Compared with industry peers like Rheinmetall (ETR:RHMG) and Renk (ETR:R3NK), Hensoldt is projected to lag in sales growth for the fourth year running, nudging up just 10% in 2026. The company's focus on "later-cycle" product lines and ongoing capacity constraints contribute to this pedestrian outlook, underscoring a more bumpy road than previously thought.

Despite these short-term headwinds, J.P. Morgan still recognizes Hensoldt as Germany's "national champion" in defense electronics with promising organic growth prospects well beyond 2030. However, concerns over earnings quality, driven by exceptional charges and heavy R&D capitalization, plus an already full valuation, weigh on the near-term picture.

The updated analysis also places downward pressure on the firm's price target, lowering it 9% to €100 for December 2026. Key risk factors include the unpredictability of defense budgets across Europe and Germany, the challenges tied to scaling up production capabilities, and uncertainties surrounding planned mergers and acquisitions designed to boost sales by €500 million by 2030.

J.P. Morgan's patience seems tested by the extended timeline and extra spending needed to fulfill Hensoldt's growth ambitions. While they acknowledge that the investments are the right moves, the bumps in execution and delays in financial rewards are creating a more subdued market sentiment.

This development leaves an open question: can Hensoldt accelerate its turnaround to catch up with its peers, or will the drag from investments and product cycles keep it in the slower lane for a while?